Comparable drug levels and immunogenicity in patients with axial spondyloarthritis treated with adalimumab originator and biosimilar: A retrospective study from two centers of China.
Saved in:
| Title: | Comparable drug levels and immunogenicity in patients with axial spondyloarthritis treated with adalimumab originator and biosimilar: A retrospective study from two centers of China. |
|---|---|
| Authors: | Fu, Zhong‐Chao1 (AUTHOR), Cheng, Xiao‐Gui2 (AUTHOR), Zhang, Guo‐Wen3 (AUTHOR), Shi, Ran‐Geng1 (AUTHOR), Zhang, Li‐Jun3 (AUTHOR), Sun, Hai‐Tian4 (AUTHOR), Huang, Jin‐Xian5 (AUTHOR) huangjx@hku‐szh.org |
| Source: | International Journal of Rheumatic Diseases. May2024, Vol. 27 Issue 5, p1-3. 3p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
